NCT04945265

Brief Summary

Infertility is a life changing disorder, affecting 1 in 7 couples within the UK. Treatment options pose a significant cost burden to both the NHS and patient when NHS-funded treatment options are exhausted. This highlights the need for refinements in clinical management strategies for this patient group. Although there have been advancements in assisted reproductive technologies, the success rates of techniques such as in vitro fertilization (IVF) remain low. Surprisingly, the IVF hormonal regimens used by most assisted conception units fail to take account of patient age, ovarian reserve or cause of infertility when deciding on treatment regimen, with a 'one size fits all' approach to treatment. The investigators propose that age and cause of infertility modify the functions and environment provided by the cells (granulosa cells) that support egg (oocyte) growth and development and understanding these changes will allow for a more personalised approach to IVF treatment regimens. The aim of this study therefore is to recruit female patients undergoing IVF with different causes of infertility and age, and harvest granulosa cells from remaining material (follicular aspirates) generated at the time of egg retrieval. Granulosa cells will be cultured in vitro and cellular functions assessed. The investigators will also recruit female patients with normal fertility undergoing IVF procedure due to other reasons (i.e. egg freezing, diagnostics of genetic diseases on embryos).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2021

Longer than P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 25, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 30, 2021

Completed
1 day until next milestone

Study Start

First participant enrolled

July 1, 2021

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2024

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

July 7, 2021

Status Verified

June 1, 2021

Enrollment Period

3 years

First QC Date

June 25, 2021

Last Update Submit

July 1, 2021

Conditions

Keywords

ovarygranulosa cellsinfertilityageing

Outcome Measures

Primary Outcomes (1)

  • Assessment of hormone production, protein and RNA expression

    Assessed via cellular signalling responses to endocrine stimulation, production of steroid hormones, protein analysis and RNA analysis

    0-14 days

Secondary Outcomes (1)

  • Correlation of cellular responses with age and cause of infertility.

    12 months

Study Arms (11)

Women aged <30

Women aged 30-36

Women aged 37-40

Women aged >40

Women undergoing egg freezing/male factor infertility/genetic testing

unidentified cause of infertility

PCOS

endometriosis

tubal disorders

ovulatory disorders

other causes of infertility e.g., fibroids.

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Women undergoing routine IVF treatment as part of their clinical treatment plan.

You may qualify if:

  • Any woman that is:
  • fluent in English,
  • capable of giving consent,
  • reproductive age (between the ages of 18-45),
  • is HIV and Hep A and Hep B negative.
  • undergoing IVF treatment for one of the following reasons:
  • unexplained infertility
  • tubal disease
  • egg freezing
  • polycystic ovarian syndrome
  • ovulatory disorders
  • endometriosis
  • male factor infertility
  • any other cause of infertility such as fibroids.

You may not qualify if:

  • Adults unable to consent for themselves,
  • Non-fluent English speakers, unless in clinic translators are available
  • Aged less than 18
  • Is HIV or Hep A or B positive, or has not undergone screening.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Infertility, FemaleInfertility

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 25, 2021

First Posted

June 30, 2021

Study Start

July 1, 2021

Primary Completion

July 1, 2024

Study Completion

June 1, 2025

Last Updated

July 7, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share